Effects of physical exercise combined with captopril or losartan on left ventricular hypertrophy of hypertensive rats.
Data
2021
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Background: Left ventricular hypertrophy (LVH) is an endpoint of hypertensive cardiac alterations. Renin-
angiotensin-aldosterone system (RAAS) blockers are among the most effective on LVH regression. Physical
exercise combined to antihypertensive drug contributes to arterial pressure (AP) control and LVH
prevention. We evaluated the effects of physical exercise combined to captopril or losartan during
eight weeks for spontaneously hypertensive rats (SHR) on some cardiac parameters.
Methods: SHR (n=5-6 per group) were sedentary or trained 5 days a week in treadmill during 8 weeks; and
they were treated with daily oral captopril (12.5, 25, or 50mg/kg), losartan (2.5, 5, or 10mg/kg), or vehicle.
At the end, it was obtained systolic AP (SAP), electrocardiogram (ECG), and hearts metalloproteinase 2
(MMP-2) activity and histology.
Results: Captopril 25 and 50 mg/kg, and losartan 10 mg/kg lowered SAP of sedentary and trained SHR.
Losartan 5 mg/kg combined with physical exercise also lowered SAP. Combined with exercise, captopril
50 mg/kg lowered 13.6% of QT interval, 14.2% of QTc interval, and 22.8% of Tpeak-Tend compared to
sedentary SHR. Losartan 5 and 10mg/kg lowered QT interval of sedentary and trained SHR. Losartan 2.5, 5
and 10mg/kg combined with physical exercise lowered respectively 25.4%, 24.8%, and 31.8% of MMP-2
activity. Losartan (10mg/kg) combined with exercise reduced cardiomyocyte diameter.
Conclusion: These data support the hypothesis of physical exercise combined with RAAS blockers could
improve the benefits on hypertensive LVH treatment.
Descrição
Palavras-chave
Cardiac hypertrophy, Spontaneous hypertensive rats, Treadmill exercise, Electrocardiogram, Renin- angiotensin system blockers
Citação
CASTRO, Q. J. T. de. et al. Effects of physical exercise combined with captopril or losartan on left ventricular hypertrophy of hypertensive rats. Clinical and Experimental Hypertension, v. 43, n. 6, 2021. Disponível em: <https://www.tandfonline.com/doi/full/10.1080/10641963.2021.1907399>. Acesso em: 11 out. 2022.